These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 28162233

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Anticonvulsant profiles of certain new 6-aryl-9-substituted-6,9-diazaspiro-[4.5]decane-8,10-diones and 1-aryl-4-substituted-1,4-diazaspiro[5.5]undecane-3,5-diones.
    Aboul-Enein MN, El-Azzouny AA, Attia MI, Maklad YA, Aboutabl ME, Ragab F, Abd El-Hamid WH.
    Int J Mol Sci; 2014 Sep 23; 15(9):16911-35. PubMed ID: 25250910
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Synthesis, anticonvulsant properties and 5-HT1A/5-HT2A receptor affinity of new N-[(4-arylpiperazin-1-yl)-propyl]-2-aza-spiro[4.4]nonane and [4.5]decane-1,3-dione derivatives.
    Obniska J, Kołaczkowski M, Charakchieva-Minol S, Nedza K, Dybała M, Bojarski AJ.
    Pharmacol Rep; 2005 Sep 23; 57(3):336-44. PubMed ID: 15985716
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Anticonvulsant properties of N-(4-methylpiperazin-1-yl)- and N-[3-(4-methyl-piperazin-1-yl)propyl] derivatives of 3-aryl- and 3-spirocycloalkyl-pyrrolidine-2,5-dione.
    Obniska J, Jurczyk S, Zejc A, Kamiński K, Tatarczyńska E, Stachowicz K.
    Pharmacol Rep; 2005 Sep 23; 57(2):170-5. PubMed ID: 15886415
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. New (arylalkyl)azole derivatives showing anticonvulsant effects could have VGSC and/or GABAAR affinity according to molecular modeling studies.
    Sari S, Karakurt A, Uslu H, Kaynak FB, Çalış Ü, Dalkara S.
    Eur J Med Chem; 2016 Nov 29; 124():407-416. PubMed ID: 27597416
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Synthesis and pharmacological evaluation of novel 1'-[2-(difluoromethoxy)benzyl]-2'H,5'H-spiro[8-azabicyclo[3.2.1]octane-3,4'-imidazolidine]-2',5'-diones and their derivatives.
    Madaiah M, Prashanth MK, Revanasiddappa HD, Veeresh B.
    Arch Pharm (Weinheim); 2014 May 29; 347(5):370-80. PubMed ID: 24446334
    [Abstract] [Full Text] [Related]

  • 17. Design, synthesis and pharmacological evaluation of N-[4-(4-(alkyl/aryl/heteroaryl)-piperazin-1-yl)-phenyl]-carbamic acid ethyl ester derivatives as novel anticonvulsant agents.
    Kumari S, Mishra CB, Tiwari M.
    Bioorg Med Chem Lett; 2015 Mar 01; 25(5):1092-9. PubMed ID: 25619635
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and preliminary evaluation of some substituted coumarins as anticonvulsant agents.
    Amin KM, Rahman DE, Al-Eryani YA.
    Bioorg Med Chem; 2008 May 15; 16(10):5377-88. PubMed ID: 18467106
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Synthesis and anticonvulsant activity of N-3-arylamide substituted 5,5-cyclopropanespirohydantoin derivatives.
    He X, Zhong M, Zhang T, Wu W, Wu Z, Yang J, Xiao Y, Pan Y, Qiu G, Hu X.
    Eur J Med Chem; 2010 Dec 15; 45(12):5870-7. PubMed ID: 20947222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.